{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:31:58Z","timestamp":1790652718963,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["R01HS022728"],"award-info":[{"award-number":["R01HS022728"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002567","name":"American Academy of Allergy Asthma and Immunology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002567","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.jaip.2018.11.023","type":"journal-article","created":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T17:31:46Z","timestamp":1543685506000},"page":"1253-1260.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["Drug Hypersensitivity Reactions Documented in Electronic Health Records within a Large Health System"],"prefix":"10.1016","volume":"7","author":[{"given":"Adrian","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane L.","family":"Seger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth H.","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Foster R.","family":"Goss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly G.","family":"Blumenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2018.11.023_bib1","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1056\/NEJM199102073240605","article-title":"The nature of adverse events in hospitalized patients: results of the Harvard Medical Practice Study II","volume":"324","author":"Leape","year":"1991","journal-title":"N\u00a0Eng J Med"},{"key":"10.1016\/j.jaip.2018.11.023_bib2","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/bcp.12293","article-title":"A\u00a0systematic review of hospitalization resulting from medicine-related problems in adult patients","volume":"78","author":"Al Hamid","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaip.2018.11.023_bib3","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/pds.4184","article-title":"Burden of hospitalizations related to adverse drug events in the USA: a retrospective analysis from large inpatient database","volume":"26","author":"Poudel","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jaip.2018.11.023_bib4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1001\/jama.1997.03540280039031","article-title":"Adverse drug events in hospitalized patients: excess length of stay, extra costs, and attributable mortality","volume":"277","author":"Classen","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2018.11.023_bib7","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1001\/archinte.167.16.1752","article-title":"Serious adverse drug events reported to the Food and Drug Administration, 1998-2005","volume":"167","author":"Moore","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaip.2018.11.023_bib9","first-page":"1","article-title":"International drug monitoring: the role of national centres","volume":"498","year":"1972","journal-title":"World Health Organ Tech Rep Ser"},{"key":"10.1016\/j.jaip.2018.11.023_bib10","first-page":"1781","article-title":"Adverse drug reactions: types and treatment options","volume":"68","author":"Riedl","year":"2003","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.jaip.2018.11.023_bib11","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/all.12350","article-title":"International consensus on drug allergy","volume":"69","author":"Demoly","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2018.11.023_bib12","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1093\/ajhp\/58.14.1317","article-title":"Potential risks and prevention, part 1: fatal adverse drug events","volume":"58","author":"Kelly","year":"2001","journal-title":"Am J Health-Syst Pharm"},{"key":"10.1016\/j.jaip.2018.11.023_bib13","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/j.1365-2125.2010.03774.x","article-title":"Epidemiology and risk factors for drug allergy","volume":"71","author":"Thong","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaip.2018.11.023_bib14","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1111\/all.12881","article-title":"Drug allergies documented in electronic health records of a large healthcare system","volume":"71","author":"Zhou","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2018.11.023_bib15","doi-asserted-by":"crossref","first-page":"778.e1","DOI":"10.1016\/j.amjmed.2009.01.034","article-title":"Self-reported antibiotic allergy incidence and prevalence: age and sex effects","volume":"122","author":"Macy","year":"2009","journal-title":"Am J Med"},{"key":"10.1016\/j.jaip.2018.11.023_bib16","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.anai.2011.11.006","article-title":"Multiple drug intolerance syndrome: prevalence, clinical characteristics, and management","volume":"108","author":"Macy","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2018.11.023_bib17","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/jamia\/ocx139","article-title":"A\u00a0value set for documenting adverse reactions in electronic health","volume":"25","author":"Goss","year":"2018","journal-title":"J\u00a0Am Med Inform Assoc"},{"key":"10.1016\/j.jaip.2018.11.023_bib18","first-page":"1639","article-title":"Using Medical Text Extraction, Reasoning and Mapping System (MTERMS) to process medication information in outpatient clinical notes","volume":"2011","author":"Zhou","year":"2011","journal-title":"AMIA Annu Symp Proc"},{"key":"10.1016\/j.jaip.2018.11.023_bib19","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/jamia\/ocv143","article-title":"Rising drug allergy alert overrides in electronic health records: an observational retrospective study of a decade of experience","volume":"23","author":"Topaz","year":"2016","journal-title":"J\u00a0Am Med Inform Assoc"},{"key":"10.1016\/j.jaip.2018.11.023_bib20","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jaip.2018.08.013","article-title":"Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome identified in the electronic health record allergy module","volume":"7","author":"Wolfson","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2018.11.023_bib21","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1001\/jama.296.15.1858","article-title":"National surveillance of emergency department visits for outpatient adverse drug events","volume":"296","author":"Budnitz","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2018.11.023_bib22","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1159\/000354918","article-title":"Clinical features and prognostic factors in severe cutaneous drug reactions","volume":"162","author":"Yang","year":"2013","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2018.11.023_bib23","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/cid\/ciu126","article-title":"Severe cutaneous adverse reactions related to systemic antibiotics","volume":"58","author":"Lin","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaip.2018.11.023_bib24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.5414\/CN10838","article-title":"Acute interstitial nephritis\u2014a reappraisal and update","volume":"82","author":"Raghavan","year":"2014","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.jaip.2018.11.023_bib25","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S1081-1206(10)60621-7","article-title":"Female sex as a risk factor for penicillin allergy","volume":"99","author":"Park","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2018.11.023_bib26","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1111\/all.13440","article-title":"Multiple drug intolerance syndrome and multiple drug allergy syndrome: epidemiology and associations with anxiety and depression","volume":"73","author":"Blumenthal","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2018.11.023_bib27","doi-asserted-by":"crossref","first-page":"e42261","DOI":"10.1371\/journal.pone.0042261","article-title":"Age-specific sex-related differences in infections: a statistical analysis of national surveillance data in Japan","volume":"7","author":"Eshima","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2018.11.023_bib28","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.anai.2017.02.003","article-title":"Clinical features of adolescents with chronic idiopathic or spontaneous urticarial: review of omalizumab clinical trials","volume":"118","author":"Goldstein","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2018.11.023_bib29","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1080\/00365540410027184","article-title":"Erythema nodosum: an experience of 10 years","volume":"36","author":"Mert","year":"2004","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jaip.2018.11.023_bib30","doi-asserted-by":"crossref","first-page":"79","DOI":"10.5114\/reum.2016.60217","article-title":"Erythema nodosum\u2014review of the literature","volume":"54","author":"Chowaniec","year":"2016","journal-title":"Reumatologia"},{"key":"10.1016\/j.jaip.2018.11.023_bib31","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/ndt\/gfs143","article-title":"Increased prevalence of acute tubulointerstitial nephritis","volume":"28","author":"Goicoechea","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jaip.2018.11.023_bib32","first-page":"533","article-title":"Risk factors for acute renal failure: inherent and modifiable risks","volume":"11","author":"Leblanc","year":"2005","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.jaip.2018.11.023_bib33","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0009-9236(96)90161-7","article-title":"Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema","volume":"60","author":"Brown","year":"1996","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaip.2018.11.023_bib34","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1002\/lary.24777","article-title":"Risk factors associated with severe and recurrent angioedema: an epidemic linked to ACE-inhibitors","volume":"124","author":"Loftus","year":"2014","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaip.2018.11.023_bib35","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1001\/archderm.138.8.1019","article-title":"Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study","volume":"138","author":"Auquier-Dunant","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaip.2018.11.023_bib36","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/428486a","article-title":"A\u00a0marker for Stevens-Johnson syndrome","volume":"428","author":"Chung","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.jaip.2018.11.023_bib37","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jaip.2014.10.002","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: a cross-sectional analysis of patients in an integrated allergy repository of a large health care system","volume":"3","author":"Blumenthal","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2018.11.023_bib38","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/pds.3778","article-title":"Identification of Stevens-Johnson syndrome and toxic epidermal necrolysis in electronic health record databases","volume":"24","author":"Davis","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jaip.2018.11.023_bib39","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1111\/j.1365-2222.2004.02070.x","article-title":"Self-reported drug allergy in a general adult Portuguese population","volume":"34","author":"Gomes","year":"2004","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2018.11.023_bib40","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2165\/00002018-200124080-00004","article-title":"Drug-induced angioedema without urticarial: incidence, prevention and management","volume":"24","author":"Agostoni","year":"2001","journal-title":"Drug Safety"},{"key":"10.1016\/j.jaip.2018.11.023_bib41","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1081-1206(10)60594-7","article-title":"Multicenter study of patients with angiotensin-converting enzyme inhibitor-induced angioedema who present to the emergency department","volume":"100","author":"Banerji","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2018.11.023_bib42","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/all.12168","article-title":"Severe drug-induced anaphylaxis: analysis of 333 cases recorded by the Allergy Vigilance Network from 2002 to 2010","volume":"68","author":"Renaudin","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2018.11.023_bib43","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1365-2125.1993.tb04157.x","article-title":"A\u00a0population-based case-cohort study of drug-induced anaphylaxis","volume":"35","author":"Van der Klauw","year":"1993","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaip.2018.11.023_bib44","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/jgs.14796","article-title":"How common are pulmonary and hepatic adverse effects in older adults prescribed nitrofurantoin?","volume":"65","author":"Claussen","year":"2017","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jaip.2018.11.023_bib45","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1093\/jac\/dkv147","article-title":"Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials","volume":"70","author":"Huttner","year":"2015","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jaip.2018.11.023_bib46","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/ndt\/gfg464","article-title":"The changing profile of acute tubulointerstitial nephritis","volume":"19","author":"Baker","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jaip.2018.11.023_bib47","doi-asserted-by":"crossref","first-page":"E166","DOI":"10.9778\/cmajo.20140074","article-title":"Proton pump inhibitors and the risk of acute kidney injury in older patients: a population-based cohort study","volume":"3","author":"Antoniou","year":"2015","journal-title":"CMAJ Open"},{"key":"10.1016\/j.jaip.2018.11.023_bib48","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/j.1365-4632.2010.04785.x","article-title":"Severe adverse cutaneous drug eruptions: epidemiological and clinical features","volume":"50","author":"Zaraa","year":"2011","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaip.2018.11.023_bib49","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.burns.2016.07.026","article-title":"Steven Johnson syndrome and toxic epidermal necrolysis in a burn unit: a 15-year experience","volume":"43","author":"McCullough","year":"2017","journal-title":"Burns"},{"key":"10.1016\/j.jaip.2018.11.023_bib50","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jaip.2018.06.010","article-title":"Drug-induced anaphylaxis documented in electronic health records","volume":"7","author":"Dhopeshwarkar","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2018.11.023_bib51","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.iac.2009.04.004","article-title":"Perioperative anaphylaxis","volume":"29","author":"Mertes","year":"2009","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2018.11.023_bib52","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0190-9622(87)70198-4","article-title":"Primary care physicians\u2019 errors in handling cutaneous disorders: a prospective survey","volume":"17","author":"Pariser","year":"1987","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2018.11.023_bib53","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s11606-014-3102-8","article-title":"Accuracy of race, ethnicity, and language preference in an electronic health record","volume":"30","author":"Klinger","year":"2015","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.jaip.2018.11.023_bib54","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.2105\/AJPH.93.10.1734","article-title":"Agreement between administrative data and patients\u2019 self-reports of race\/ethnicity","volume":"93","author":"Kressin","year":"2003","journal-title":"Am J Public Health"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219818307517?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219818307517?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:18:35Z","timestamp":1761974315000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219818307517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S2213219818307517"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2018.11.023","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug Hypersensitivity Reactions Documented in Electronic Health Records within a Large Health System","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2018.11.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}